South Korea · Delayed Price · Currency is KRW JW Pharmaceutical Statistics
Total Valuation
KRX:001060 has a market cap or net worth of KRW 505.50 billion. The enterprise value is 523.71 billion.
| Market Cap | 505.50B |
| Enterprise Value | 523.71B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KRX:001060 has 22.89 million shares outstanding. The number of shares has decreased by -2.44% in one year.
| Current Share Class | 22.55M |
| Shares Outstanding | 22.89M |
| Shares Change (YoY) | -2.44% |
| Shares Change (QoQ) | -0.81% |
| Owned by Insiders (%) | 0.81% |
| Owned by Institutions (%) | 8.35% |
| Float | 12.90M |
Valuation Ratios
The trailing PE ratio is 10.41.
| PE Ratio | 10.41 |
| Forward PE | n/a |
| PS Ratio | 0.68 |
| PB Ratio | 1.56 |
| P/TBV Ratio | 1.62 |
| P/FCF Ratio | 11.99 |
| P/OCF Ratio | 9.78 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.68, with an EV/FCF ratio of 12.42.
| EV / Earnings | 10.68 |
| EV / Sales | 0.71 |
| EV / EBITDA | 4.68 |
| EV / EBIT | 5.62 |
| EV / FCF | 12.42 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.41 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 0.82 |
| Debt / FCF | 2.15 |
| Interest Coverage | 9.15 |
Financial Efficiency
Return on equity (ROE) is 17.16% and return on invested capital (ROIC) is 13.55%.
| Return on Equity (ROE) | 17.16% |
| Return on Assets (ROA) | 9.15% |
| Return on Invested Capital (ROIC) | 13.55% |
| Return on Capital Employed (ROCE) | 25.53% |
| Revenue Per Employee | 695.55M |
| Profits Per Employee | 45.92M |
| Employee Count | 1,068 |
| Asset Turnover | 1.18 |
| Inventory Turnover | 3.47 |
Taxes
In the past 12 months, KRX:001060 has paid 36.66 billion in taxes.
| Income Tax | 36.66B |
| Effective Tax Rate | 41.33% |
Stock Price Statistics
The stock price has decreased by -18.82% in the last 52 weeks. The beta is 1.06, so KRX:001060's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -18.82% |
| 50-Day Moving Average | 22,378.00 |
| 200-Day Moving Average | 22,659.70 |
| Relative Strength Index (RSI) | 45.68 |
| Average Volume (20 Days) | 41,866 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:001060 had revenue of KRW 742.85 billion and earned 49.04 billion in profits. Earnings per share was 2,112.48.
| Revenue | 742.85B |
| Gross Profit | 344.19B |
| Operating Income | 91.82B |
| Pretax Income | 88.71B |
| Net Income | 49.04B |
| EBITDA | 110.60B |
| EBIT | 91.82B |
| Earnings Per Share (EPS) | 2,112.48 |
Balance Sheet
The company has 72.53 billion in cash and 90.73 billion in debt, giving a net cash position of -18.20 billion or -795.31 per share.
| Cash & Cash Equivalents | 72.53B |
| Total Debt | 90.73B |
| Net Cash | -18.20B |
| Net Cash Per Share | -795.31 |
| Equity (Book Value) | 323.28B |
| Book Value Per Share | 14,124.92 |
| Working Capital | 94.37B |
Cash Flow
In the last 12 months, operating cash flow was 51.71 billion and capital expenditures -9.56 billion, giving a free cash flow of 42.15 billion.
| Operating Cash Flow | 51.71B |
| Capital Expenditures | -9.56B |
| Free Cash Flow | 42.15B |
| FCF Per Share | 1,841.70 |
Margins
Gross margin is 46.33%, with operating and profit margins of 12.36% and 7.01%.
| Gross Margin | 46.33% |
| Operating Margin | 12.36% |
| Pretax Margin | 11.94% |
| Profit Margin | 7.01% |
| EBITDA Margin | 14.89% |
| EBIT Margin | 12.36% |
| FCF Margin | 5.67% |
Dividends & Yields
This stock pays an annual dividend of 450.00, which amounts to a dividend yield of 2.02%.
| Dividend Per Share | 450.00 |
| Dividend Yield | 2.02% |
| Dividend Growth (YoY) | 12.50% |
| Years of Dividend Growth | 9 |
| Payout Ratio | 21.27% |
| Buyback Yield | 2.44% |
| Shareholder Yield | 4.45% |
| Earnings Yield | 9.70% |
| FCF Yield | 8.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 27, 2023 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
KRX:001060 has an Altman Z-Score of 3.69 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.69 |
| Piotroski F-Score | 7 |